Bill117th CongressFiled Jun 14, 2022Health
S. 4390
Accelerated Approval Transparency Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in senate (Jun 14, 2022)
Accelerated Approval Transparency Act
This bill requires the Food and Drug Administration to include a summary of the reasons a drug or biologic received accelerated approval to treat a serious or life-threatening disease or condition in the public action package for the drug or biologic.
What just happenedJun 14, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who’s behind it
Sen. Hickenlooper, John W. [D-CO](D-CO)Sponsor
1committees2actions
- Introduced in SenateJun 14, 2022
- Jun 14, 2022IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health, Education, Labor, and Pensions Committee - Jun 14, 2022IntroReferral10000
Introduced in Senate